One Stop Shop for All Your Market Research Reports

Global Exocrine Pancreatic Insufficiency Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Global Exocrine Pancreatic Insufficiency Market Possesses a Significant Opportunity for Major Players in Emerging Economies. Exocrine pancreatic insufficiency (EPI) is the inability to digest food properly, owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. Moreover, it is triggered by the progressive loss of pancreatic cells that generate digestive enzymes. Furthermore, exocrine pancreatic insufficiency (EPI) disturbs the normal growth, life expectancy and response from the immune system. Diarrhoea, steatorrhea, fatigue and weight loss are the key symptoms of exocrine pancreatic insufficiency (EPI). Increasing incidences of exocrine pancreatic insufficiency and demands of advanced therapeutics for treatment of exocrine pancreatic insufficiency across the globe are key factors driving growth of global exocrine pancreatic insufficiency market. Apart from these, strong presence of significant amount of pipeline drugs is also a major factor responsible for growth of global pancreatic exocrine insufficiency market. However, lack of technological reach and awareness among the general population in many parts of emerging economies are key restraints for growth of global exocrine pancreatic insufficiency market. Strict regulatory measures and difficulty in gaining approvals for drugs by regulatory authorities is a major factor affecting growth of global exocrine pancreatic insufficiency market. In developed regions, rising geriatric population and minimum death rates are key opportunities for growth of global exocrine pancreatic insufficiency market. Moreover, emerging economies such as India and China portray a great scope for growth of global exocrine pancreatic market, owing to rising awareness among the general population and technological advancements in these regions. The global exocrine pancreatic insufficiency market report has been segmented on the basis of therapeutics, diagnostic tests and region. The markets in North America, and Europe dominated the global exocrine pancreatic insufficiency market in terms of revenue, owing to high public awareness about EPI and availability of advanced treatment methods. Asia pacific market is expected to expand significantly over the forecast period obtaining the highest CAGR of X.X%, mainly due to its high geriatric population and accelerated demand for accurate and reliable treatment of exocrine pancreatic insufficiency (EPI). Global exocrine pancreatic insufficiency market segmentation by therapeutics:
  • Pancreatic Enzyme Replacement Therapy (PERT) Drugs
    • Creon
    • Zenpep
    • Pancreaze
    • Ultresa
    • Viokace
    • Pertzye
  • Exocrine Pancreatic Insufficiency Drugs, Pipeline Analysis, Sollpura (Liprotamase)
Global exocrine pancreatic insufficiency market segmentation by diagnostic tests:
  • Blood Tests
  • Endoscopic Ultra-Sonography (EUS)
  • Magnetic Resonance Imaging (MRI)
  • CT Scanning
Global exocrine pancreatic insufficiency market segmentation by region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key players in the global pancreatic insufficiency market include,
  • Axcan
  • Aptalis Pharma Inc.
  • Eli Lilly & Co.
  • Cilian AG
  • Nordmark Arzneimittel GmbH & Co.KG
  • Laboratoires Mayoly Spindler
  • Abbvie Inc.
  • Allergan plc
  • Digestive Carew Inc.
  • Cilian AG
  • Anthera Pharmaceuticals Inc.
  • AzuRx Biopharma, Inc.
Report Structure: In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with research methodology and a list of acronyms and sources used to gather and analyse data and information. The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others. The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers. Objective of Report: Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors. Who we are and what we do: Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies. Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.
Request for Table of Contents

Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ $ 4395
Multi User US $6395
Corporate User US $9395
About this Report
Report ID 148087
Category
  • Pharmaceuticals and Healthcare
Published on Upcoming
Number of Pages NA
Publisher Name Prudour
Editor Rating
★★★★★
★★★★★
(0)